New Combination Approaches to Enhance Rituximab Based Lymphoma Therapies

New Combination Approaches to Enhance Rituximab Based Lymphoma Therapies
Author: Anonim
Publsiher: Academic Press
Total Pages: 250
Release: 2020-11-01
ISBN 10: 0128167378
ISBN 13: 9780128167373
Language: EN, FR, DE, ES & NL

New Combination Approaches to Enhance Rituximab Based Lymphoma Therapies Book Review:

New Combination Approaches to Enhance Rituximab-Based Lymphoma Therapies provides general updated information on the resistance of various human lymphoma/leukemia subtypes to anti-CD20 therapeutic antibodies. It discusses also the description of various targeted sensitizing agents that can reverse innate or acquired resistance when used in combination with various FDA-approved anti-CD20 antibodies. There have been a lot of reports in which the treatment with anti-CD20 antibodies for various lymphomas/leukemias has resulted in significant clinical responses; however, there have been also subsets of cancer patients who did not respond initially and several of the responding patients developed resistance to subsequent treatments with the same or different regimens. Therefore, the use of various immunosensitizing agents targeting resistant factors to reverse resistance has been considered and this book discusses each of them in depth, such as Bortexomib, Immunomodulation Agents, Obinutuzumab, Tumor Suppressors, and HDAC Inhibitors. This book is a valuable source for cancer researchers, oncologists, pharmacologists and different members of biomedical field interested in fighting cancer resistance to anti-CD20 antibodies. Provides a general overview of various sensitizing agents that can work effectively when used in combination with anti-CD20 antibodies to reverse resistance Offers potential underlying mechanisms by which the cancer cells are either inherently resistant or become unresponsive to further antibody treatments Discusses how to develop new targeted agents to underlie resistance in order to expand research on this field

Resistance to Targeted Therapies in Lymphomas

Resistance to Targeted Therapies in Lymphomas
Author: Ana C. Xavier,Mitchell S. Cairo
Publsiher: Springer Nature
Total Pages: 210
Release: 2019-09-13
ISBN 10: 3030244245
ISBN 13: 9783030244248
Language: EN, FR, DE, ES & NL

Resistance to Targeted Therapies in Lymphomas Book Review:

Over the past few decades, lymphoma patient outcomes have improved as a result of multidrug chemotherapy and radiation therapy, intensification of treatment, improvement in supportive care, and better imaging and staging systems. Even more recently, there has been tremendous progress in the understanding of cancer cell biology and its microenvironment which has resulted in the development of biologic agents, also called "target" therapies. These therapies are more specific in targeting cancer cells either directly or via enhancement of the immune system. Many clinical studies have focused on biological agents in combination with traditional chemotherapy with the goal of improved outcomes, or reduced acute long term complications that are associated with lymphoma therapy. This volume will review different classes of "target" drugs that have been developed, approved, or are under investigation in the field of lymphoma therapy. The discussion will not only be on the understanding of the mechanisms of action or clinical response of those agents, but will also help the reader to understand the nature of lymphoma biology in patients who relapse or are refractor after exposure to those drugs. Contributors will discuss what is currently known about mechanisms of tumor-related or host-related resistance, and how to overcome this resistance. This understanding is crucial given the dismal outcomes of patients with relapsed or refractory lymphomas. The book provides a unique opportunity to review and reflect on the recent successes and pitfalls of the modern lymphoma therapy era.

The Lymphoid Neoplasms 3ed

The Lymphoid Neoplasms 3ed
Author: Ian Magrath
Publsiher: CRC Press
Total Pages: 1689
Release: 2010-07-30
ISBN 10: 1444113224
ISBN 13: 9781444113228
Language: EN, FR, DE, ES & NL

The Lymphoid Neoplasms 3ed Book Review:

This comprehensive and authoritative reference covers all aspects of the group of disorders collectively known as the lymphoid neoplasms. The reader is taken through a description of its normal cellular origins and the molecular genetic abnormalities that can lead to this group of conditions, a section of the book that has been considerably strengthened for this third edition, to the environmental factors that may be relevant to disease development, and, finally, to the pragmatic aspects of disease management. The authors synthesise for the reader apsects of current knowledge and likely future developments, and direct them to the appropriate resources should they wish to pursue particular avenues of scientific or literature research.

Advances in Lymphoma Research

Advances in Lymphoma Research
Author: Fernando Cabanillas,M. Alma Rodriguez
Publsiher: Springer Science & Business Media
Total Pages: 169
Release: 2012-12-06
ISBN 10: 1461541298
ISBN 13: 9781461541295
Language: EN, FR, DE, ES & NL

Advances in Lymphoma Research Book Review:

Fernando Cabanillas In 1993, Fisher et al. published the results of a randomized trial comparing three third-generation regimens against the classic CHOP combination. For several years, the oncology community had been convinced that the third generation regimens were clearly superior to CHOP. It came as a shock to many that there was no difference in outcome between the four arms of this clinical trial. The logical conclusion is that CHOP is as good as any of the other regimens tested in that study. Unfortunately, this excellent study has been misinterpreted by many as proving that there has not been any progress in the field of lymphoma during the last 20 years. Furthermore, it has led to a fatalistic attitude in the reasoning of many clinicians who feel that 'nothing works better than CHOP' and therefore that it is not worth testing new drugs or developing novel regimens. However, the process by which we move forward in the oncology field is seldom by dramatic breakthroughs. Frequently, what appears at first glance to be a breakthrough turns out later to be just a modest step forward. Several steps forward eventually add up to a major advance, but this advance goes unnoticed because of the slow nature of the process. In this volume, we have chosen to discuss several of these steps, which we feel are clearly making a positive impact on the field of lymphomas and which soon should make a major difference in therapeutic results.

Goldman s Cecil Medicine Expert Consult Premium Edition Enhanced Online Features and Print Single Volume 24

Goldman s Cecil Medicine Expert Consult Premium Edition    Enhanced Online Features and Print  Single Volume 24
Author: Russell La Fayette Cecil,Lee Goldman,Andrew I. Schafer
Publsiher: Elsevier Health Sciences
Total Pages: 2655
Release: 2012-01-01
ISBN 10: 1437716040
ISBN 13: 9781437716047
Language: EN, FR, DE, ES & NL

Goldman s Cecil Medicine Expert Consult Premium Edition Enhanced Online Features and Print Single Volume 24 Book Review:

Since 1927, Goldman-Cecil Medicine has been the world's most influential internal medicine resource. In the ground-breaking 25th edition, your original purchase ensures you will be up-to-date without the need for a subscription. Through the new, more powerful Expert Consult eBook platform, this "living text" provides continuous updates that will integrate the latest research, guidelines, and treatments into each chapter, ensuring that the content is as current as the day this edition was first published. Goldman-Cecil Medicine offers definitive, unbiased guidance on the evaluation and management of every medical condition, presented by a veritable "Who's Who" of modern medicine. A practical, straightforward style; templated organization; evidence-based references; and robust interactive content combine to make this dynamic resource quite simply the fastest and best place to find all of the authoritative, state-of-the-art clinical answers you need. "The content is superb, authoritative and not surprisingly very up to date." Reviewed by: Dr Harry Brown, on behalf of Glycosmedia Date: July 2015 Expert Consult eBook version included with print purchase: Access continuous updates from Editor Lee Goldman, MD, who thoroughly reviews internal medicine and specialty journals, updating online content to reflect the latest guidelines and translating that evidence into treatment. Interactive Q&A section features over 1,500 board-style questions and answers to aid in preparing for certification or recertification exams. Outstanding supplementary tools include figures, tables, videos, heart and lung sounds, treatment and management algorithms, fully integrated references, and thousands of illustrations and full-color photos. Search all of the text, figures, supplementary material, and references from the book on a variety of devices and at no additional cost - Expert Consult access is included with this title! Practical, bulleted, highly templated text with easy-to-use features including flow charts and treatment boxes. New chapters on global health, cancer biology and genetics, and the human microbiome in health and disease keep you on the cutting edge of medicine. Today's most current evidence-based medicine guidelines help you form a definitive diagnosis and create the best treatment plans possible. Focused coverage of the latest developments in biology includes the specifics of current diagnosis, therapy, and medication doses. The reference of choice for every stage of your career! Goldman-Cecil Medicine is an ideal learning tool for residents, physicians, and students as well as a valuable go-to resource for experienced healthcare professionals. Cecil - the best internal medicine resource available since 1927 - far exceeds the competition in versatility, ease-of-use and up-to-datedness.

Combinatorial Approaches to Enhance Anti Tumor Immunity Focus on Immune Checkpoint Blockade Therapy

Combinatorial Approaches to Enhance Anti Tumor Immunity  Focus on Immune Checkpoint Blockade Therapy
Author: Patrik Andersson,Christian Ostheimer
Publsiher: Frontiers Media SA
Total Pages: 316
Release: 2019-12-27
ISBN 10: 2889631613
ISBN 13: 9782889631612
Language: EN, FR, DE, ES & NL

Combinatorial Approaches to Enhance Anti Tumor Immunity Focus on Immune Checkpoint Blockade Therapy Book Review:

The immune system harbors great potential for controlling and eliminating tumors. Recent developments in the field of immuno-oncology has led to unprecedented clinical benefits for a broad spectrum of solid tumors. However, immunotherapy (IT) approaches currently have several limitations including (i) low response rate; (ii) development of resistance and (iii) causing severe immune-related adverse effects (IrAEs), which underline the importance of adequate patient selection. Importantly, IT holds promising synergistic potential when combined with standard-of-care chemotherapy, radiotherapy (RT) and anti-angiogenic therapy (AAT) as part of multi-modal oncologic treatment regimes. Published data suggest that there are potential synergy between RT and AAT, which ultimately could help potentiate the response to IT. However, the complex interactions between RT and IT and/or AAT remain poorly understood. Many research questions including optimal timing, scheduling and dosing, as well as patient selection and side effects of combined therapy approaches, remain to be addressed. This Research Topic aims to give a comprehensive overview of the current field with particular emphasis on the future outlook of RT and AAT as complementary approaches to improve IT in solid tumors.

Non Hodgkin Lymphoma

Non Hodgkin Lymphoma
Author: Andrew M. Evens,Kristie A. Blum
Publsiher: Springer
Total Pages: 344
Release: 2015-02-06
ISBN 10: 3319131508
ISBN 13: 9783319131504
Language: EN, FR, DE, ES & NL

Non Hodgkin Lymphoma Book Review:

This book provides clinical practitioners and the research community with detailed information on the diagnosis, prognosis, and treatment of non-Hodgkin lymphoma, taking into account the significant growth in knowledge including multiple therapeutic advances that have been achieved over the past 5-10 years. The work is subdivided into epidemiology, pathogenesis, pathology, imaging, and therapy of the non-Hodgkin lymphomas. The full range of therapeutic options are examined according to the major subtypes of non-Hodgkin lymphoma and the most up-to-date information is provided on current standard treatment options, including stem cell transplantation as well as new cutting-edge therapeutics.

Neoplastic Diseases of the Blood

Neoplastic Diseases of the Blood
Author: Peter H. Wiernik,John M. Goldman,Janice P. Dutcher,Robert A. Kyle
Publsiher: Springer Science & Business Media
Total Pages: 1431
Release: 2012-09-22
ISBN 10: 1461437644
ISBN 13: 9781461437642
Language: EN, FR, DE, ES & NL

Neoplastic Diseases of the Blood Book Review:

Neoplastic Diseases of the Blood integrates the history, epidemiology, pathology, pathophysiology, and therapeutics of modern neoplastic hematopathology. The book is divided into five major sections, with the first four covering the spectrum of hematologic neoplasia— Chronic Leukemias and Related Disorders , Acute Leukemias, Myeloma and Related Disorders, and Lymphomas. The fifth section covers a variety of topics in supportive care. Now in its fifth edition, this classic and invaluable text brings together a team of internationally renowned experts and offers in-depth coverage of the complex interface between diagnosis and therapy. Chapters feature an accessible and easy-to-read layout and provide updates on the tremendous progress made in the last decade in the understanding of the nature of hematologic malignancies and their treatment. An authoritative and indispensable resource for students, trainees, and clinicians, this fifth edition is sure to distinguish itself as the definitive reference on this topic.

Drug Benefits and Risks

Drug Benefits and Risks
Author: C.J. van Boxtel,B. Santoso,I.R. Edwards
Publsiher: IOS Press
Total Pages: 848
Release: 2008-08-06
ISBN 10: 160750345X
ISBN 13: 9781607503453
Language: EN, FR, DE, ES & NL

Drug Benefits and Risks Book Review:

This updated and revised 2nd edition of Drug Benefits and Risks is an inclusive reference exploring the scientific basis and practice of drug therapy. The key concept is to look at the balance between the benefits and risks of drugs, but in this context also highlighting the social impact which drugs have in modern societies. Taking an evidence-based approach to the problem, the practice of clinical pharmacology and pharmacotherapy in the developing as well as the developed world is examined. For this purpose the book covers general clinical pharmacology, pharmacology of various drug groups and the treatments specific to various diseases; the book gives guidance on how doctors should act so that drugs can be used effectively and safely; and it encourages the rational use of drugs in society. This publication brings together a large amount of excellent content that will be invaluable for anyone working within, or associated with, the field of clinical pharmacology and pharmacotherapy - undergraduates, postgraduates, regulatory authorities and the pharmaceutical industry.

Postgraduate Review MCQs in Hematology

Postgraduate Review  MCQs in Hematology
Author: Sanjeev Kumar Sharma,Pawan Kumar Singh
Publsiher: Jaypee Brothers Medical Publishers
Total Pages: 464
Release: 2021-11-30
ISBN 10: 9354650651
ISBN 13: 9789354650659
Language: EN, FR, DE, ES & NL

Postgraduate Review MCQs in Hematology Book Review:

Principles of Cancer Biotherapy

Principles of Cancer Biotherapy
Author: Robert K. Oldham,Robert O. Dillman
Publsiher: Springer Science & Business Media
Total Pages: 742
Release: 2009-08-29
ISBN 10: 9789048122899
ISBN 13: 9048122899
Language: EN, FR, DE, ES & NL

Principles of Cancer Biotherapy Book Review:

At the time of the first edition of Principles of Cancer Biotherapy in 1987, this book represented the first comprehensive textbook on biological therapy. In 1991, when the second edition was published, there was still some doubt on the part of many oncologists and cancer researchers as to the therapeutic value of these new approaches. By 2003 and the fourth edition, it was generally agreed that biopharmaceuticals were producing major opportunities for new cancer therapies. Cancer biotherapy has now truly matured into the fourth modality of cancer treatment. This fifth revised edition describes the tremendous progress that has been made in recent years using biologicals in cancer treatment. This book summarizes an evolving science and a rapidly changing medical practice in biotherapy. In this new millennium, it is now possible to envision a much more diversified system of cancer research and treatment that will afford greater opportunities for a patient’s personalized cancer treatment. This was first envisioned in the 1987 initial edition of this textbook and is now a “new” and popular approach to cancer treatment. Some forms of cancer biotherapy use the strategy of tumor stabilization and control through continued biological therapy, akin to the use of insulin in the treatment of diabetes. This textbook illustrates new methods of thinking and new strategies for control of cancer. It is always difficult to move from past dogma to future opportunity, but this fifth edition of Principles of Cancer Biotherapy illustrates why it is so important to the patients for researchers and clinicians to explore and quickly apply these new opportunities in cancer biotherapy.

Methods of Cancer Diagnosis Therapy and Prognosis

Methods of Cancer Diagnosis  Therapy  and Prognosis
Author: M. A. Hayat
Publsiher: Springer Science & Business Media
Total Pages: 476
Release: 2010-04-07
ISBN 10: 9789048131860
ISBN 13: 9048131863
Language: EN, FR, DE, ES & NL

Methods of Cancer Diagnosis Therapy and Prognosis Book Review:

There are more than 100 types of cancers In Part II, head and neck cancer is d- affecting all parts of the human body. cussed. The global number of annual new More than 11 million people are diagnosed cases of this malignancy is ~500,000. These with cancer every year, and it is estimated malignancies include oral squamous cell that there will be 16 million new cases by carcinoma, salivary gland tumors, tons- the year 2020. In 2005, 7. 6 million peo- lar cancer, tongue cancer, nasopharyngeal ple died of cancer, that is, 13% of the 58 carcinoma, and retinoblastoma, which are million deaths worldwide. It is estimated detailed. In Part III, diagnosis, therapy, and that 9 million people will die from can- prognosis of thyroid carcinoma are d- cer worldwide in 2015 and 11. 4 million cussed. The global number of new cases of will die in 2030. More than 70% of all thyroid cancer is ~141,000, and the number cancer deaths occur in low and middle of worldwide thyroid mortalities is ~35,375. income countries. These statistics underlie The number of new cases of this cancer in the fact that cancer is the deadliest of all the United States is ~33,550. Molecular human diseases. The enormity of the glo- genetics of thyroid cancer, gene expr- bal healthcare costs as a result of cancer sion markers for diagnosis, papillary t- cannot be overemphasized.

Perry s The Chemotherapy Source Book

Perry s The Chemotherapy Source Book
Author: Michael C. Perry,Donald C. Doll,Carl E. Freter
Publsiher: Lippincott Williams & Wilkins
Total Pages: 848
Release: 2012-07-30
ISBN 10: 1469803437
ISBN 13: 9781469803432
Language: EN, FR, DE, ES & NL

Perry s The Chemotherapy Source Book Book Review:

Perry’s The Chemotherapy Source Book, now in its fifth edition, provides information on the choice of chemotherapeutic agents, the use of combination chemotherapy, and the toxicity of individual drugs. Organized by site, this is the only book of its kind to focus strictly on the clinical practice of chemotherapy, and is meant to serve as a “one-stop shop” for information on choice of chemotherapeutic agents, treatment outlines, grading of side effects, and dose modification.

Management of Lymphomas A Case Based Approach

Management of Lymphomas  A Case Based Approach
Author: Jasmine Zain,Larry W. Kwak
Publsiher: Springer
Total Pages: 204
Release: 2017-04-28
ISBN 10: 3319268279
ISBN 13: 9783319268279
Language: EN, FR, DE, ES & NL

Management of Lymphomas A Case Based Approach Book Review:

This book will provide an overview of how to manage patients with lymphoma in the format of a series of engaging case studies. Lymphomas are cancers that originate in the lymphatic system. There are two main types of lymphoma: Hodgkin lymphoma and non-Hodgkin lymphoma. These lymphomas comprise various subtypes with prognosis and treatment depending on the stage and type of the cancer. Lymphoma is a major global health problem; non-Hodgkin lymphoma in particular is the tenth most common type of cancer worldwide. In response to this there have been a number of significant advances in the available treatment options for lymphoma with new breakthrough drugs being approved or registered for approval. In light of this, this case study book will be an extremely timely guide for all hematologists, oncologists, and healthcare professionals wishing to keep up-to-date with these recent developments. The format of this book is also particularly appealing as it offer readers a practical approach to the clinical management of patients with these conditions as suggested by leading physicians from the City of Hope National Medical Center in California, USA in an era of vast therapeutic development.

Resistance to Ibritumomab in Lymphoma

Resistance to Ibritumomab in Lymphoma
Author: Makoto Hosono,Jean-François Chatal
Publsiher: Springer
Total Pages: 158
Release: 2018-04-24
ISBN 10: 331978238X
ISBN 13: 9783319782386
Language: EN, FR, DE, ES & NL

Resistance to Ibritumomab in Lymphoma Book Review:

This volume, in discussing resistance to ibritumomab, will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects, and medical physics that deal with radiation dosimetry, and will outline future prospects for overcoming resistance and enhancing efficacy of ibritumomab.

UICC Manual of Clinical Oncology

UICC Manual of Clinical Oncology
Author: James D. Brierley,Anil D'Cruz,Martin Fey,Raphael E. Pollock,Jan Vermorken,Shao Hui Huang
Publsiher: John Wiley & Sons
Total Pages: 856
Release: 2015-07-28
ISBN 10: 1119013127
ISBN 13: 9781119013129
Language: EN, FR, DE, ES & NL

UICC Manual of Clinical Oncology Book Review:

The Manual of Clinical Oncology, Ninth Edition, published with the International Union Against Cancer (UICC), provides a concise, accessible and feasible reference covering state of art multidisciplinary clinical oncology in order to meet the needs of clinicians caring for cancer patients throughout the world. Edited by world-renowned practising oncologists and written by key opinion leaders, this book contains authoritative and up-to-date information on cancer detection, diagnosis and treatment alongside topics such as survivorship, special populations and palliative care. Remodelled and revised for the ninth edition to provide practical information to oncology workers, the UICC Manual of Clinical Oncology is structured in two parts. Part 1 covers general principles of cancer diagnosis and management with additional attention to special settings in oncology, including supportive care and survivorship, and Part 2 covers site-specific multidisciplinary cancer management. The edition includes up-to-date summaries of all treatment modalities (medical, surgical and radiation) for all tumour sites. It also contains the latest TNM classifications outlined in the TNM Classification of Malignant Tumours. The ninth edition includes: Practical presentation with bullet points, tables, and flow charts intended to facilitate quick reference for day-to-day clinical practice in busy oncology environments, Representation of multidisciplinary care for site specific management, Evidence-based approaches to management, including specific treatment recommendations and investigations guided by clinical practice guidelines, State of art evidence-based recommendations that take into consideration the lack of availability of certain medications or resources, as well as practice variations, in different and remote regions of the world, and Contemporary topics on cancer treatment, such as cancer informatics, evidence levels, principles of prognostication, survivorship and cancer in pregnancy. Oncologists, oncologists-in-training, nurses working with cancer patients and other health professionals responsible for treating and caring for those with cancers will find the UICC Manual of Clinical Oncology an indispensable and comprehensive resource.

Targeted Therapies in Cancer

Targeted Therapies in Cancer
Author: Manfred Dietel
Publsiher: Springer Science & Business Media
Total Pages: 262
Release: 2007-06-10
ISBN 10: 3540460918
ISBN 13: 9783540460916
Language: EN, FR, DE, ES & NL

Targeted Therapies in Cancer Book Review:

From its introduction, oncological chemotherapy has been encumbered by poor selectivity because antiproliferative drugs are often toxic not only to tumor cells but also to important populations of the body’s non-neoplastic cells. Modern targeted therapies interact with defined molecules present on cancer cells, adding increased selectivity to their toxic effects. This book presents an integrated critical view on the theories, mechanisms, problems and pitfalls of the targeted therapy approach.

Conn s Current Therapy 2019

Conn s Current Therapy 2019
Author: Rick D. Kellerman,David Rakel
Publsiher: Elsevier Health Sciences
Total Pages: 1344
Release: 2018-12-06
ISBN 10: 0323596509
ISBN 13: 9780323596503
Language: EN, FR, DE, ES & NL

Conn s Current Therapy 2019 Book Review:

Follows a consistent, easy-to-use format throughout, with diagnosis, therapy, drug protocols, and treatment pearls presented in quick-reference boxes and tables for point-of-care answers to common clinical questions. Features significantly revised chapters on sepsis • bacterial pneumonia • ADHD • endometriosis • atrial fibrillation • congestive heart failure • pericarditis • diabetes mellitus • measles • myasthenia gravis • irritable bowel syndrome • Parkinson’s disease • seizures and epilepsy in adolescents and adults • acute bronchitis and other viral respiratory illnesses • urinary incontinence • neutropenia • venous thromboembolism • fungal diseases of the skin • diseases of the nails • and more. Includes all-new chapters on fatty liver, pancreatic cancer, and more. Includes nearly 300 images, including algorithms, anatomical illustrations, and photographs, that provide useful information for diagnosis. Provides current drug information thoroughly reviewed by PharmDs. Shares the knowledge and expertise of 40 new authors who provide a fresh perspective in their specialties.

Cummings Otolaryngology Head and Neck Surgery E Book

Cummings Otolaryngology   Head and Neck Surgery E Book
Author: Paul W. Flint,Bruce H. Haughey,K. Thomas Robbins,Valerie J. Lund,J. Regan Thomas,John K. Niparko,Mark A. Richardson,Marci M. Lesperance
Publsiher: Elsevier Health Sciences
Total Pages: 3672
Release: 2010-03-09
ISBN 10: 0323080871
ISBN 13: 9780323080873
Language: EN, FR, DE, ES & NL

Cummings Otolaryngology Head and Neck Surgery E Book Book Review:

Through four editions, Cummings Otolaryngology has been the world's most trusted source for comprehensive guidance on all facets of head and neck surgery. This 5th Edition - edited by Paul W. Flint, Bruce H. Haughey, Valerie J. Lund, John K. Niparko, Mark A. Richardson, K. Thomas Robbins, and J. Regan Thomas – equips you to implement all the newest discoveries, techniques, and technologies that are shaping patient outcomes. You'll find new chapters on benign neoplasms, endoscopic DCR, head and neck ultrasound, and trends in surgical technology... a new section on rhinology... and coverage of hot topics such as Botox. Plus, your purchase includes access to the complete contents of this encyclopedic reference online, with video clips of key index cases! Overcome virtually any clinical challenge with detailed, expert coverage of every area of head and neck surgery, authored by hundreds of leading luminaries in the field. See clinical problems as they present in practice with 3,200 images - many new to this edition. Consult the complete contents of this encyclopedic reference online, with video clips of key index cases! Stay current with new chapters on benign neoplasms, endoscopic DCR, head and neck ultrasound, and trends in surgical technology... a new section on rhinology... and coverage of hot topics including Botox. Get fresh perspectives from a new editorial board and many new contributors. Find what you need faster through a streamlined format, reorganized chapters, and a color design that expedites reference.

Withrow and MacEwen s Small Animal Clinical Oncology E Book

Withrow and MacEwen s Small Animal Clinical Oncology   E Book
Author: David M. Vail,Douglas Thamm,Julias Liptak
Publsiher: Elsevier Health Sciences
Total Pages: 864
Release: 2019-07-23
ISBN 10: 0323594972
ISBN 13: 9780323594974
Language: EN, FR, DE, ES & NL

Withrow and MacEwen s Small Animal Clinical Oncology E Book Book Review:

Considered the definitive reference on canine and feline oncology, Withrow & MacEwen's Small Animal Clinical Oncology, 6th Edition focuses on the most effective, cutting-edge techniques. This comprehensive textbook gives you a complete understanding of cancer in dogs and cats — what it is, how to diagnose it, and how to treat many of the most common cancers encountered in clinical practice today. The thoroughly updated sixth edition includes information on the complications of cancer, pain management, and the latest treatment modalities — preparing general practitioners to diagnose and treat pets rather than referring them to a specialist. With important updates on recently approved and in-development drugs, and new co-authors adding their own unique perspectives, this user-friendly text is a must-have resource for current, evidence-based therapeutic strategies on canine and feline oncology. Cutting-edge information on the complications of cancer, pain management, and the latest treatment modalities prepares you to diagnose and treat pets with cancer rather than refer cases to a specialist. Each contributor is a recognized expert in his or her specialty, reflecting the most current information by highly respected experts in the field of veterinary oncology. Full-color format provides you with accurate visual depictions of specific diseases and procedures, enhances visual appeal, and is used functionally in tables and boxes to highlight key information. A systems approach to the diagnosis and management of cancer facilitates access to information about the many malignancies affecting small animal patients. Discussion of compassion and supportive care for the management of pain, nutritional needs, and grief includes methods for handling the pet’s pain and nutritional complications as well as the pet owner’s grief when treatment is not successful. Comprehensive references at the end of each chapter and topic ensures you can be confident the information provided is accurate and up to date. Helpful drug formularies provide quick access to information on indications, toxicities, and recommended dosages for chemotherapeutic and analgesic drugs used in cancer treatment. Chemotherapy protocols are included when case studies prove clinical efficacy. Information on the best interventional techniques is quickly accessible all in one chapter. Nearly 400 color images provide accurate depictions of specific diseases and procedures. Focus on the most effective treatment options saves time by emphasizing proven treatment options that have been vetted by experts in the field. NEW! Expert co-authors and contributors bring a valuable perspective with research experience. NEW! Thoroughly UPDATED content includes important updates on recently approved and in-development veterinary cancer drugs, and critical advances in radiation delivery.